The effect of aspirin on circulating tumor cells in metastatic colorectal and breast cancer patients: a phase II trial study
ConclusionAspirin could decrease CTCs numbers and block EMT transition in MCC patients and part of MBC patients.
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research
More News: Aspirin | Breast Cancer | Cancer | Cancer & Oncology | Clinical Trials | Colorectal Cancer | Epithelial Cancer | Study